Disease progression in people with Parkinson’s disease can be accurately monitored using sensors, removing some of the limitations of wearable technologies, a new study reports.
Scientists can use patient-derived tissue samples to grow miniature versions of human organs, allowing them to test new medications and disease treatments for personalized care.
SUNNYVALE, Calif., July 13, 2026 /PRNewswire/ — Embolx, Inc., a leader in advanced microcatheter technology for targeted embolization procedures, today announced that the Centers for Medicare & Medicaid Services (CMS) has established a new HCPCS Level II code, G0577, covering Sniper® procedures performed in the physician office, or office-based lab (OBL), setting. The new code took effect July 1, 2026.
STOCKHOLM, July 13, 2026 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the US Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once weekly lecanemab irmb subcutaneous injection (US brand name: Leqembi Iqlik®) as a starting dose for the treatment of early Alzheimer’s disease. The US launch is planned for late August 2026.
HistoSonics announced today that it received CE mark approval for its Edison non-invasive histotripsy technology platform.
Claria Medical announced today that it received FDA de novo authorization for its Claria system for minimally invasive hysterectomies.
Abbott (NYSE:ABT) announced today that the FDA approved the longer length (76 mm) Esprit BTK drug-eluting scaffold system.